首页> 外文期刊>Journal of AOAC International >Identification and Quantification of Nonviable Lactobacillus pentosus Cells in a Health Food Product
【24h】

Identification and Quantification of Nonviable Lactobacillus pentosus Cells in a Health Food Product

机译:在保健食品中鉴定和定量非等乳酸杆菌细胞的抑制细胞

获取原文
获取原文并翻译 | 示例
           

摘要

Background: The lack of formal protocol to verify the nonviable cell probiotic product authenticity blocks its registration and supervision process. Objective: To develop a protocol for identification, enumeration, and purity determination of a Lactobacillus pentosus nonviable cell product. Methods: The 16S ribosomal RNA (rRNA) sequencing, 16S rRNA metagenomic analysis, whole-genome sequencing, matrix-assisted laser desorption ionization time of flight MS (MALDI-TOF-MS), and FACSMicroCount (TM) system were applied to establish a protocol of identification, enumeration and purity determination of a Lactobacillus pentosus nonviable cell product. Results: The 1530 bp of 16S rRNA sequence could only identify the bacteria at genus level, but the MALDI-TOF-MS could identify both the nonviable cell and fresh culture to species level with high confidence. Metagenomic analysis of the 16S rRNA amplicon could recognize Lactobacillus as the dominant genus in the nonviable cell product. The total number of matching k-mers between the nonviable cell product and the L. pentosus BGM48 in the GenBank was the highest. The 95% confidence interval of the nonviable cell concentration in the product was determined as 4.31-4.68x10(10) cells/g through the BD FACSMicroCount system. Conclusions: This validation protocol offers an executable approach that can verify microbial contents in nonviable cell products and ensure the compliance with label claims. Highlights: The established validation protocol could determine the nonviable cell species through MALDI-TOF-MS, the concentration through FACSMicroCount system, and the purity and strain level identification through metagenomic analysis of 16S rRNA and the genomic deoxyribonucleic acid.
机译:背景:缺乏正式议定书,以验证不可行的细胞益生菌产品真实性阻止其登记和监督过程。目的:制定乳杆菌戊叶非活化细胞产物的鉴定,枚举和纯度测定方案。方法:16S核糖体RNA(rRNA)测序,16S rRNA偏焦体分析,全基因组测序,飞行飞行MS的基质辅助激光解吸电离时间(MALDI-TOF-MS)和Facsmicrocount(TM)系统进行建立乳酸杆菌非活性细胞产物的鉴定,枚举和纯度测定鉴定,募集和纯度测定。结果:16S rRNA序列的1530bp只能鉴定属级别的细菌,但MALDI-TOF-MS可以高度置信地识别不可行的细胞和新鲜培养物。 16S rRNA扩增子的Metagenomic分析可以将乳酸杆菌识别为非活性细胞产物中的显性属。在Genbank中的非活细胞产物和L.Pentosus BGM48之间的匹配K-MERS总数是最高的。通过BD Facsmicrocount系统测定产物中不可行细胞浓度的95%置信区间为4.31-4.68x10(10)个细胞/ g。结论:该验证协议提供可执行方法,可以可执行方法,可以验证非可变细胞产品中的微生物内容,并确保符合标签要求。亮点:所建立的验证方案可以通过MALDI-TOF-MS,通过面向运动系统的浓度来确定非活化的细胞物种,以及通过16S rRNA和基因组脱氧核酸的分析分析的纯度和应变水平鉴定。

著录项

  • 来源
    《Journal of AOAC International》 |2020年第1期|共4页
  • 作者单位

    Natl Inst Food &

    Drug Control 1-2 Tiantan Xili Beijing 100050 Peoples R China;

    Hebei Food Inspect &

    Res Inst Hebei Food Safety Key Lab 537 Zhonghua S St Shijiazhuang 050071 Hebei Peoples R China;

    Natl Inst Food &

    Drug Control 1-2 Tiantan Xili Beijing 100050 Peoples R China;

    Natl Inst Food &

    Drug Control 1-2 Tiantan Xili Beijing 100050 Peoples R China;

    Natl Inst Food &

    Drug Control 1-2 Tiantan Xili Beijing 100050 Peoples R China;

    Natl Inst Food &

    Drug Control 1-2 Tiantan Xili Beijing 100050 Peoples R China;

    Natl Inst Food &

    Drug Control 1-2 Tiantan Xili Beijing 100050 Peoples R China;

    Natl Inst Food &

    Drug Control 1-2 Tiantan Xili Beijing 100050 Peoples R China;

    Natl Inst Food &

    Drug Control 1-2 Tiantan Xili Beijing 100050 Peoples R China;

    Natl Inst Food &

    Drug Control 1-2 Tiantan Xili Beijing 100050 Peoples R China;

  • 收录信息
  • 原文格式 PDF
  • 正文语种 eng
  • 中图分类 分析化学;
  • 关键词

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号